Submitted on May 3, 2019 - USP Comment Letter to FDA on the draft guidance, “Nonproprietary Naming of Biological Products: Update. Docket No. FDA-2013-D-1543.
USP-comments-to-FDA-on-CBER-nomenclature.pdf
(170.15 KB)
Submitted on May 3, 2019 - USP Comment Letter to FDA on the draft guidance, “Nonproprietary Naming of Biological Products: Update. Docket No. FDA-2013-D-1543.